| Ambulatory pulse wave velocity is a stronger predictor of cardiovascular events and all-cause mortality than office and ambulatory blood pressure in hemodialysis patients PA Sarafidis, C Loutradis, A Karpetas, G Tzanis, A Piperidou, ... Hypertension 70 (1), 148-157, 2017 | 114 | 2017 |
| Ambulatory recording of wave reflections and arterial stiffness during intra-and interdialytic periods in patients treated with dialysis A Karpetas, PA Sarafidis, PI Georgianos, A Protogerou, P Vakianis, ... Clinical Journal of the American Society of Nephrology 10 (4), 630-638, 2015 | 87 | 2015 |
| Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran P Malindretos, PA Sarafidis, I Rudenco, V Raptis, K Makedou, A Makedou, ... American journal of nephrology 27 (6), 572-579, 2007 | 54 | 2007 |
| Role of asymmetrical dimethylarginine in the progression of renal disease V Raptis, S Kapoulas, D Grekas Nephrology 18 (1), 11-21, 2013 | 53 | 2013 |
| Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA … PA Sarafidis, F Mallamaci, C Loutradis, R Ekart, C Torino, A Karpetas, ... Nephrology Dialysis Transplantation 34 (9), 1542-1548, 2019 | 51 | 2019 |
| Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in … G Koutroumbas, PI Georgianos, PA Sarafidis, A Protogerou, A Karpetas, ... Nephrology Dialysis Transplantation 30 (12), 2046-2053, 2015 | 51 | 2015 |
| The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients PA Sarafidis, C Loutradis, A Karpetas, G Tzanis, A Bikos, V Raptis, ... Nephrology Dialysis Transplantation 34 (3), 515-523, 2019 | 39 | 2019 |
| Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease V Raptis, PI Georgianos, PA Sarafidis, A Sioulis, K Makedou, A Makedou, ... Kidney and Blood Pressure Research 38 (1), 72-82, 2014 | 38 | 2014 |
| New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies S Kapoulas, V Raptis, M Papaioannou Néphrologie & Thérapeutique 11 (3), 135-143, 2015 | 35 | 2015 |
| Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease PI Georgianos, I Liampas, A Kyriakou, V Vaios, V Raptis, N Savvidis, ... International urology and nephrology 49, 2217-2221, 2017 | 27 | 2017 |
| Adaptation and validation of the Kidney Disease Quality of Life-Short Form questionnaire in the Greek language P Malindretos, P Sarafidis, S Spaia, A Sioulis, N Zeggos, V Raptis, V Kitos, ... American journal of nephrology 31 (1), 9-14, 2010 | 27 | 2010 |
| Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts V Raptis, C Loutradis, PA Sarafidis Nephrology Dialysis Transplantation 33 (11), 1887-1895, 2018 | 23 | 2018 |
| Levels of endocan, angiopoietin-2, and hypoxia-inducible factor-1a in patients with autosomal dominant polycystic kidney disease and different levels of renal function V Raptis, C Bakogiannis, C Loutradis, AK Boutou, I Lampropoulou, ... American Journal of Nephrology 47 (4), 231-238, 2018 | 21 | 2018 |
| Hypoxia and endothelial dysfunction in autosomal-dominant polycystic kidney disease M Theodorakopoulou, V Raptis, C Loutradis, P Sarafidis Seminars in Nephrology 39 (6), 599-612, 2019 | 18 | 2019 |
| Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study F Mallamaci, C Torino, P Sarafidis, R Ekart, C Loutradis, K Siamopoulos, ... Journal of hypertension 38 (9), 1849-1856, 2020 | 16 | 2020 |
| Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension C Loutradis, A Bikos, V Raptis, Z Afkou, G Tzanis, N Pyrgidis, ... Hypertension Research 42 (7), 1001-1010, 2019 | 16 | 2019 |
| The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study A Bikos, C Loutradis, E Angeloudi, A Karpetas, V Raptis, R Kalaitzidis, ... Journal of Hypertension 37 (2), 432-442, 2019 | 15 | 2019 |
| Serum Fas ligand, serum myostatin and urine TGF-β1 are elevated in autosomal dominant polycystic kidney disease patients with impaired and preserved renal function V Raptis, C Bakogiannis, C Loutradis, AK Boutou, A Sioulis, E Balaskas, ... Kidney and Blood Pressure Research 43 (3), 744-754, 2018 | 15 | 2018 |
| Calcification of coronary arteries and aortic valve and circulating a-klotho levels in patients with chronic kidney disease P Savvoulidis, AP Kalogeropoulos, V Raptis, V Rafailidis, PI Georgianos, ... Journal of Thoracic Disease 12 (3), 431, 2020 | 14 | 2020 |
| Accuracy of peridialytic, intradialytic, and scheduled interdialytic recordings in detecting elevated ambulatory blood pressure in hemodialysis patients P Sarafidis, MP Theodorakopoulou, C Loutradis, F Iatridi, ME Alexandrou, ... American Journal of Kidney Diseases 78 (5), 630-639. e1, 2021 | 7 | 2021 |
Pantelis SarafidisAristotle University of ThessalonikiVerified email at auth.gr
